CHROMA MEDICINE
Summary
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 205 M
Avg. Deal Size£ 103 M
All rights reserved. Copyright © 2025 Datasite
Summary
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Catherine Stehman-Breen
CEO
Brett Kaplan
CFO
Vic Myer
President and CSO